QUEBEC CITY, March 12, 2013 /PRNewswire/ - Aeterna Zentaris Inc.
(NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce its fourth
quarter and full-year 2012 financial and operating results on Thursday,
March 21, 2013, after market close. The Company will host a conference
call the next morning, Friday, March 22, 2013 at 8:30 a.m. (Eastern
Time), to discuss these results.
Participants may access the live webcast via the Company's website at www.aezsinc.com in the "Newsroom" section, or by telephone using the following numbers:
in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.
A replay of the webcast will also be available on the Company's website
for a period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company's pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information, please visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.